Topamax Sprinkle Alternatives Compared
| Topamax Sprinkle (topiramate) | Topiramate | Aimovig (erenumab) |
|
|---|
| Topamax Sprinkle (topiramate) | Topiramate | Aimovig (erenumab) |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Lennox-Gastaut Syndrome, Migraine Prevention, Epilepsy, Seizure Prevention, Seizures. Topamax Sprinkle may also be used for purposes not listed in this medication guide. |
Prescription only
Topiramate may be prescribed either alone or in combination with other medications for the treatment of certain types of epilepsy, or it may be given for the prevention of migraines. Drowsiness is a... View more |
Prescription only
Aimovig is used to prevent migraines in adults and is self-administered as a subcutaneous injection once a month. Injection site reactions (pain, redness, or swelling) and constipation are the most... View more |
Related suggestions Migraine Prevention (Migraine Prophylaxis)
|
|||||||||||||||||||||||
| More about (topiramate) | More about Topiramate | More about Aimovig (erenumab) | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Topamax Sprinkle has an average rating of 1.8 out of 10 from a total of 4 ratings on Drugs.com. 0% of reviewers reported a positive effect, while 100% reported a negative effect. |
Topiramate has an average rating of 6.3 out of 10 from a total of 1338 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 28% reported a negative effect. |
Aimovig has an average rating of 5.2 out of 10 from a total of 649 ratings on Drugs.com. 38% of reviewers reported a positive effect, while 43% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
|
View all Topamax Sprinkle side effects |
View all Topiramate side effects |
View all Aimovig side effects |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
| Lower cost generic approved |
Lower cost generic |
N/A |
||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Topamax Sprinkle prices |
View all Topiramate prices |
View all Aimovig prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Other topiramate brands include: Eprontia, Qudexy XR, Topamax, Trokendi XR | Eprontia, Qudexy XR, Topamax, Trokendi XR |
N/A |
||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
56 hours |
56 hours |
672 hours |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 291 drugs are known to interact with Topamax Sprinkle:
|
A total of 291 drugs are known to interact with Topiramate:
|
A total of 3 drugs are known to interact with Aimovig:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
N/A |
December 24, 1996 |
May 17, 2018 |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
|
N/A |
||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
|
N/A |
||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.